CG
GENE

Cutler Group’s Genetic Technologies Ltd. GENE Stock Holding History

Cutler Group’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20
Closed – – 6329
2021
Q3 		$0 Hold
20
– – ﹤0.01% 6545
2021
Q2 		$0 Sell
20
-1,780
-99% -$35.9K ﹤0.01% 6544
2021
Q1 		$37K Buy
1,800
+789
+78% +$18.1K ﹤0.01% 2677
2020
Q4 		$18K Buy
1,011
+906
+863% +$15K ﹤0.01% 2772
2020
Q3 		$1K Sell
105
-60
-36% -$1.12K ﹤0.01% 4514
2020
Q2 		$1K Hold
165
– – ﹤0.01% 4222
2020
Q1 		$1K Sell
165
-100
-38% -$1.59K ﹤0.01% 3858
2019
Q4 		$2K Hold
265
– – ﹤0.01% 3549
2019
Q3 		$2K Hold
265
– – ﹤0.01% 3583
2019
Q2 		$3K Sell
265
-5
-2% -$77 ﹤0.01% 3450
2019
Q1 		$4K Hold
270
– – ﹤0.01% 3103
2018
Q4 		$2K Sell
270
-5
-2% -$103 ﹤0.01% 3478
2018
Q3 		$5K Buy
275
+35
+15% +$795 ﹤0.01% 3096
2018
Q2 		$4K Hold
240
– – ﹤0.01% 3291
2018
Q1 		$4K Hold
240
– – ﹤0.01% 3473
2017
Q4 		$5K Hold
240
– – ﹤0.01% 3701
2017
Q3 		$3K Hold
240
– – ﹤0.01% 4901
2017
Q2 		$4K Hold
240
– – ﹤0.01% 5115
2017
Q1 		$5K Hold
240
– – ﹤0.01% 4788
2016
Q4 		$5K Buy
240
+215
+860% +$5.96K ﹤0.01% 4972
2016
Q3 		$0 Buy
+25
New +$1.02K ﹤0.01% 7540

Other funds holding GENE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cutler Group's GENE Position: Q4 2021 in Review

Cutler Group sold out of Genetic Technologies Ltd. (GENE) in Q4 2021, closing a stake of 20 shares.

Cutler Group first reported a position in GENE in Q3 2016 and held it in 21 quarters. The position peaked at $37K in Q1 2021. 13 funds tracked by Wall St. Rank hold GENE as of Q4 2021.

  • Cutler Group reported no remaining Genetic Technologies Ltd. position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 20 Genetic Technologies Ltd. shares in Q4 2021.
  • Cutler Group first reported a position in Genetic Technologies Ltd. in Q3 2016 and held it in 21 quarters.
  • Cutler Group's Genetic Technologies Ltd. position peaked at $37K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.